Results 131 to 140 of about 49,298 (201)

Juvenile rheumatoid arthritis (Juvenile chronic arthritis)

Dermatology Online Journal, 2001
openaire   +4 more sources

Case Report: Novel <i>UNC93B1</i> variant causes rheumatoid arthritis and interstitial pneumonia. [PDF]

Front Immunol
He T, Ou J, Huang L, Zhou X, Wang L, Li X, Yang J.   +6 more
europepmc   +1 more source

Highlights on the Contribution of Gut Microbiota to Immune-Mediated Diseases in Childhood. [PDF]

Mediterr J Hematol Infect Dis
Pelanda H, Rulli E, Sultanov M, Adornato S, Rigante D.   +4 more
europepmc   +1 more source

PRO-KIND consensus protocol for classification, monitoring, and therapy in pediatric rheumatology: persistent oligoarticular juvenile idiopathic arthritis. [PDF]

Front Pediatr
Peitz J, Horneff G, Raab A, Winowski H, Hansmann S, Tenbrock K.   +5 more
europepmc   +1 more source

Adult-Onset Still's Disease Presenting with Progressive Motor Neuropathy. [PDF]

Eur J Case Rep Intern Med
Freire AR, Santos N, Fernandes P, Moura D, Santos Silva A.   +4 more
europepmc   +1 more source

Tocilizumab-induced psoriatic dermatitis in polyarticular juvenile idiopathic arthritis: A rare case report. [PDF]

SAGE Open Med Case Rep
Rajesh RY, Biju Seena P, Nakhutsrishvili E, Akkineni T, Ahmed AA, Suvvari TK, Thomas V, Singh T.   +7 more
europepmc   +1 more source

Juvenile arthritis damage index predicts poor response to biological treatment: A prospective cohort study. [PDF]

World J Clin Pediatr
Kolkhidova ZA, Nikishina IP, Glukhova SI, Melikhov OG, Kostik MM.   +4 more
europepmc   +1 more source

Osteopathia striata with cranial sclerosis, associated with juvenile idiopathic arthritis: A case report and review of literature. [PDF]

World J Orthop
Yakovlev AA, Gaidar EV, Suspitsin EN, Korzun PR, Kostik MM.   +4 more
europepmc   +1 more source

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review. [PDF]

Pediatr Rheumatol Online J
Zheng R, Zou L, Li SC, Lu M.
europepmc   +1 more source

Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. [PDF]

Pharmaceuticals (Basel)
Alexeeva EI, Dvoryakovskaya TM, Nikishina IP, Zholobova ES, Matkava VG, Krekhova EA, Raupov RK, Bukhanova DV, Egorova AN, Grishin SA, Samsonov MY, Kostik MM.   +11 more
europepmc   +1 more source